NCT01292993View on ClinicalTrials.gov

A Study to Evaluate the Interaction of LX4211 and Metformin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

400 mg LX4211

400 mg of LX4211 given as a solid oral dose form

DRUG

1000 mg metformin

1000 mg metformin given as a solid oral dose form

Trial Locations (1)

78209

Lexicon Investigational Site, San Antonio

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY